Pages without language links

From IDWiki

The following pages do not link to other language versions.

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. (1,3)-β-D-glucan
  2. 7 + 3
  3. AIDS-defining illnesses
  4. AIDS-related complex (ARC)
  5. AIDS cholangiopathy
  6. ANCA-associated vaculitis
  7. ARDS ventilation protocol
  8. ARF
  9. AST:platelet ratio index
  10. A Few Antibiotics to Know
  11. A Few Bacteria to Know
  12. A Few Frameworks to Know
  13. A Few ID Resources
  14. A Few More Bacteria to Know
  15. A Few Syndromes to Know
  16. Abatacept
  17. Abdominal aortic aneurysm
  18. Abdominal compartment syndrome
  19. Abiotrophia
  20. Abnormal liver enzymes
  21. Acanthamoeba
  22. Acetazolamide
  23. Acetobacter
  24. Acetobacteraceae
  25. Achromobacter
  26. Acinetobacter
  27. Acinetobacter baumannii complex
  28. Acinetobacter lwoffii
  29. Acinetobacter pittii
  30. Acinetobacter ursingii
  31. Aconite poisoning
  32. Acquired immunodeficiency
  33. Actinomyces
  34. Actinomyces neuii
  35. Actinomycetes
  36. Actinotignum schaalii
  37. Acute aortic syndrome
  38. Acute bacterial prostatitis
  39. Acute bacterial sinusitis
  40. Acute cerebellitis
  41. Acute coronary syndrome
  42. Acute epiglottitis
  43. Acute exacerbation of COPD
  44. Acute flaccid paralysis
  45. Acute generalized exanthematous pustulosis
  46. Acute heart failure
  47. Acute hemolytic transfusion reaction
  48. Acute inflammatory edema
  49. Acute intermittent porphyria
  50. Acute kidney injury
  51. Acute kidney injury in pregnancy
  52. Acute kidney injury in renal transplant
  53. Acute loss of consciousness
  54. Acute mountain sickness
  55. Acute myeloid leukemia
  56. Acute necrotizing encephalopathy
  57. Acute promyelocytic leukemia
  58. Acute respiratory distress syndrome
  59. Acute retinal necrosis
  60. Acute rheumatic fever
  61. Acute severe headache
  62. Acute spinal cord compression
  63. Acute stroke
  64. Acute toxic leukoencephalopathy
  65. Acute triglyceridemic pancreatitis
  66. Acute urinary retention
  67. Acyclovir
  68. Adalimumab
  69. Adenovirus
  70. Adrenal insufficiency
  71. Adult-onset Still's disease
  72. Adverse drug reaction
  73. Adverse event
  74. Aerococcus
  75. Aerococcus sanguinicola
  76. Aeromonas
  77. Aflatoxin
  78. Aggregatibacter
  79. Agranulocytosis
  80. Agrobacterium
  81. Albendazole
  82. Alcaligenes
  83. Alcaligenes faecalis
  84. Alcohol, smoking and substance involvement screening test
  85. Alcohol in the elderly
  86. Alcohol use disorder
  87. Alcohol withdrawal
  88. Alcoholic hepatitis
  89. Alefacept
  90. Alemtuzumab
  91. Alkaline phosphatase
  92. Allergic bronchopulmonary aspergillosis
  93. Alpha-fetoprotein
  94. Alpha-gal syndrome
  95. Altered mental status
  96. Alternaria
  97. Alzheimer's communication strategies
  98. Alzheimer disease
  99. Amblyomma americanum
  100. Amblyomma maculatum
  101. Ambulatory blood pressure monitor
  102. Amikacin
  103. Aminoglycosides
  104. Amoxicillin-clavulanic acid
  105. AmpC β-lactamase
  106. Amphotericin B
  107. Ampicillin-sulbactam
  108. Amyloidosis
  109. Amyotrophic lateral sclerosis
  110. Anaerobiospirillum succiniciproducens
  111. Anakinra
  112. Anaphylaxis
  113. Anaplasma phagocytophilum
  114. Anemia
  115. Angioimmunoblastic T-cell lymphoma
  116. Angiostrongylus cantonensis
  117. Animal bite
  118. Anion gap metabolic acidosis
  119. Anisakidosis
  120. Anisocoria
  121. Ankylosing spondylitis
  122. Anti-nuclear antibody
  123. Antibiograms
  124. Antibiotic-associated diarrhea
  125. Antibiotic prophylaxis for open fractures
  126. Antibiotic prophylaxis for procedures
  127. Antibiotic spectrum index
  128. Antibiotics in sodium restriction
  129. Anticoagulation
  130. Antiepileptic drugs
  131. Antifungal spectrum of activity
  132. Antifungals
  133. Antimicrobial abbreviations
  134. Antimicrobial stewardship program
  135. Antimicrobials in breastfeeding
  136. Antimicrobials in pregnancy
  137. Antineutrophil cytoplasmic antibody
  138. Antipseudomonal antibiotics
  139. Antiretroviral resistance in HIV
  140. Antistreptolysin O
  141. Antiviral resistance in CMV
  142. Antiviral spectrum of activity
  143. Aortic graft infection
  144. Aortic root abscess
  145. Aortic stenosis
  146. Aortitis
  147. Aphasia
  148. Aplastic anemia
  149. Apophysomyces elegans
  150. Approach to Clinical Syndromes: Part I
  151. Arboviruses
  152. Arcanobacterium haemolyticum
  153. Artesunate
  154. Arthrocentesis of the knee
  155. Arthropods
  156. Ascaris lumbricoides
  157. Ascites
  158. Aseptic meningitis
  159. Aseptic meningitis with genital lesions
  160. Aspergillus
  161. Aspergillus oryzae
  162. Aspergillus sojae
  163. Asplenia and hyposplenia
  164. Asthma
  165. Asthma-COPD overlap syndrome
  166. Asthma in pregnancy
  167. Asymptomatic bacteriuria
  168. Asymptomatic bacteriuria in pregnancy
  169. Atopobium rimae
  170. Atovaquone
  171. Atovaquone-proguanil
  172. Atrial fibrillation
  173. Atypical femoral fracture
  174. Atypical hemolytic-uremic syndrome
  175. Atypical lymphocytosis
  176. Atypical pneumonia
  177. Aureobasidium
  178. Aureobasidium pullulans
  179. Auricular chondritis
  180. Autism spectrum disorder
  181. Autoimmune hemolytic anemia
  182. Autoimmune hepatitis
  183. Autoimmune pancreatitis
  184. Autoimmune polyendocrinopathy, candidiasis, and ectodermal dystrophy
  185. Autosomal dominant polycystic kidney disease
  186. Avian paramyxovirus type 1
  187. Azacitidine
  188. BASCULE syndrome
  189. BK virus
  190. Babesia microti
  191. Bacillary angiomatosis
  192. Bacillus
  193. Bacillus anthracis
  194. Bacillus cereus
  195. Bacteremia
  196. Bacteria
  197. Bacterial meningitis
  198. Bacterial meningitis (IDSA 2004)
  199. Bacterial vaginosis
  200. Bacteroides fragilis group
  201. Balamuthia mandrillaris
  202. Balantidium coli
  203. Baltimore classification of viruses
  204. Baricitinib
  205. Bartonella
  206. Bartonella bacilliformis
  207. Bartonella henselae
  208. Bartonella quintana
  209. Basidiobolus ranarum
  210. Basophilic stippling
  211. Baylisascaris procyonis
  212. Bedaquiline
  213. Behçet disease
  214. Behçet disease
  215. Being a Consultant
  216. Bell palsy
  217. Benign prostatic hypertrophy
  218. Benzodiazepine use disorder
  219. Benzodiazepines
  220. Bevacizumab
  221. Biapical scarring
  222. Bile esculin agar
  223. Bilirubin
  224. Biofilm
  225. Biophysical profile
  226. Biosafety risk groups
  227. Bioterrorism agents
  228. Bispecific T-cell engager
  229. Black yeasts
  230. Bladder pain syndrome
  231. Blastocystis hominis
  232. Blastomyces dermatitidis
  233. Blood-borne infections
  234. Blood culture
  235. Blood culture contamination
  236. Blood transfusion
  237. Blue-green algae
  238. Blue sclerae
  239. Body surface area
  240. Bone marrow biopsy
  241. Bony metastases
  242. Bordetella
  243. Bordetella pertussis
  244. Borrelia
  245. Borrelia burgdorferi
  246. Borrelia hermsii
  247. Borrelia mayonii
  248. Borrelia miyamotoi
  249. Borrelia parkeri
  250. Borrelia recurrentis
  251. Borrelia turicatae
  252. Bortezomib
  253. Botryomycosis
  254. Boutonniere deformity
  255. Brachial plexus syndrome
  256. Bradycardia
  257. Brain abscess
  258. Brain death
  259. Brentuximab vedotin
  260. Brevibacillus
  261. Brevundimonas
  262. Brincidofovir
  263. Brodie abscess
  264. Bronchiectasis
  265. Brucella
  266. Brucella melitensis
  267. Brugada syndrome
  268. Bunyavirales
  269. Buprenorphine
  270. Burkholderia
  271. Burkholderia cepacia complex
  272. Burkholderia mallei
  273. Burkholderia pseudomallei
  274. Burning mouth syndrome
  275. Bursitis
  276. C-reactive protein
  277. CAPS
  278. CCU drugs and concentrations
  279. CD markers
  280. CHEAP TORCHES
  281. CMV after hematopoietic stem cell transplantation
  282. CMV after solid organ transplantation
  283. CMV in HIV patients
  284. CMV in pregnancy
  285. CMV retinitis in HIV patients
  286. CNS calcifications in neonates
  287. CNS infections in HIV patients
  288. COVID-19-associated pulmonary aspergillosis
  289. CR:DOI:00acfd050b7608cdad2cda8ddc922cbf
  290. CR:DOI:0169c23afd306a21ede91427ae6dc828
  291. CR:DOI:02ebac30bd4090e729efc4a882b6c93d
  292. CR:DOI:0829a713e95cbbd4b450ed29b107c622
  293. CR:DOI:09649f204e0f789481cbf2b6e9852750
  294. CR:DOI:098bf7f228d86a0a7768623ab8017fde
  295. CR:DOI:0b4b004dd3ae98c4f75ebf3cff47e3ab
  296. CR:DOI:0b4d5fbdb5a3461e1d4ad9a0bd9c7b57
  297. CR:DOI:0bbf52c7a66f6ed4bdd0dbd95b094a7d
  298. CR:DOI:0bf8ee2ef119a747eb1ef476f7e7b719
  299. CR:DOI:0d1e5dc1202ab7a7a86f7e814306e82e
  300. CR:DOI:0f2325db60edc6b9b12ea02b0aa425e2
  301. CR:DOI:13494e2091d6ab067b36b569529e4e8c
  302. CR:DOI:143a8a4e98ce78f59bd9439c01575f67
  303. CR:DOI:14d8f96aed7b8566166d94219db9c587
  304. CR:DOI:1591ed0715e4656cc34c6ad134c82fbd
  305. CR:DOI:176b5770c3f3682ece04fcb9d7722a0c
  306. CR:DOI:18cf3d3fef3630ee3cbf73381ad15ac6
  307. CR:DOI:195968321ee211df1e7dbd126a34f592
  308. CR:DOI:19d44b0938e9b8f10c901d23de6156fb
  309. CR:DOI:1c13eb71190fd747a0ca4de5035dcf0d
  310. CR:DOI:1da74b622a953e9ec15f52a5d9406f23
  311. CR:DOI:1e05c9fa81f92bdccea40e74e189de3b
  312. CR:DOI:1e0f196e8979f77a82c63ac7c9a6256a
  313. CR:DOI:1e310ed8dee76dde0ef65abfc6ac6418
  314. CR:DOI:2030b67e3e5ece9bb99885a6c6b65add
  315. CR:DOI:20b1483903240f2c41f322f3dd0c9300
  316. CR:DOI:223da6637bb9228360819cb97fb77f2f
  317. CR:DOI:234faee71b76a3460d05a93808ef21c7
  318. CR:DOI:2367c9a916ae67d97ccfd3dd0a19f3b6
  319. CR:DOI:23eb96f7b0f18d6fd85814605a856558
  320. CR:DOI:255d85f5162682b856cfd0b102c7d93d
  321. CR:DOI:27d9c2886cfe6db6618a894fb602548c
  322. CR:DOI:293185aec9b19fa57075d19dae14d2f3
  323. CR:DOI:2c6a5b651fff9c9cbd6341dfbc9a5a36
  324. CR:DOI:2ca01566cd9046e6582daa1bf4f11b9c
  325. CR:DOI:2d3c452047be5089ceb85dbafbd2293f
  326. CR:DOI:2e0ee443bdb0d5c5c74ff7f8f34ad6e3
  327. CR:DOI:2e985fec4cbd3c0bbd083450d443effc
  328. CR:DOI:2f556ae27a0ead10bdc78afc7d591782
  329. CR:DOI:2f593bbb879ddf6273cb080b1f82f881
  330. CR:DOI:313b2c31a000cc7719c112463f068c86
  331. CR:DOI:31924dec18fa6f8a5f9c873f28f52af4
  332. CR:DOI:3220ecfd9746207590bda96a386c4a36
  333. CR:DOI:324eb4fd5a300cb39055ab08c9026796
  334. CR:DOI:351be4f8e400189bf2f9e9883575b08a
  335. CR:DOI:35deea6bca62469c53a8d1db72080a12
  336. CR:DOI:36b2aaede1423d248c277a1d68a528ac
  337. CR:DOI:371c72784a9d025db2bbe9b0f9c987a2
  338. CR:DOI:381b8d6868d4be132eeedf751c3edd0d
  339. CR:DOI:382cbd759b8401371e6f1c4551d1b3ef
  340. CR:DOI:38bbaf88b704c9b50a847fff5a13ee30
  341. CR:DOI:3c928b7df7a9405c7077dbadb984160c
  342. CR:DOI:3e6405399d321f945f2db0124b2e277f
  343. CR:DOI:3f57dcdfc0c902341df2343eaa856e3c
  344. CR:DOI:41b8b943fd352e7db17fae6598a2efc5
  345. CR:DOI:42c3d87de298a0073c36a9b9299751ff
  346. CR:DOI:45fdd9d93c8d6c80b99b6f38d0dccd38
  347. CR:DOI:46123634f2a85fd729368e2defc622c3
  348. CR:DOI:48b240d4a5da84271e0e30de474dcd52
  349. CR:DOI:48b3c3d59b243389e5f28b00d4db15f7
  350. CR:DOI:49aed2104d605ef8c28d5a0086f55319
  351. CR:DOI:4b5520861f644af6fc2c40ee3cd59320
  352. CR:DOI:4c59f810dcfde02ea4b210db2513a067
  353. CR:DOI:4c62a9e4b664859cb8d5027e0d0cbcad
  354. CR:DOI:4d444b3e3d1c4b2a93077fef5f98dde1
  355. CR:DOI:4dc6ace4215c8fc18ce986fa74da8519
  356. CR:DOI:4eb9cd71fdb59132cfc7c3dba7ad9fb4
  357. CR:DOI:4f2e8e91c22157d3b7c76e51388fa695
  358. CR:DOI:4f998a83c8e5f34dd6c814a6b14ebcfc
  359. CR:DOI:50980a9543271b913bd7bc6b0e2bc449
  360. CR:DOI:510aa6dad1509646765db21a07cc0c5a
  361. CR:DOI:51fa8f54739ab5a0e6de54d5a40a6926
  362. CR:DOI:533fdca5d7624a0a92c34442ff9c6b94
  363. CR:DOI:54261e0f60b000f250d27de501384afa
  364. CR:DOI:557ada687368f8167ededa806f865c2e
  365. CR:DOI:55f07f8124c04d4c31455e83a0c55748
  366. CR:DOI:56b67522689053f83c75be4984e0ef3a
  367. CR:DOI:56f88ff55f20b5c9e5c5a475f2466bad
  368. CR:DOI:57b132d01e0b0b10e5ff13b429bedb3c
  369. CR:DOI:5833dec2f6a1c81a835d3b7ec30850b1
  370. CR:DOI:58518b26913a03a3a4637e6abef3fb42
  371. CR:DOI:58a5342a18d98576e4a3479ebd6e5cf4
  372. CR:DOI:597122a60ca1220bc34eb933860bd38f
  373. CR:DOI:5f48b1fa391b1e412ae002eff571f917
  374. CR:DOI:60c42ee946fc6f8b9ba4d0e3baaaf7f4
  375. CR:DOI:613c770c895ebbe5fc01a70fe1b3c416
  376. CR:DOI:6146a23d59736fcd2b396575d91711ab
  377. CR:DOI:614fcb9a3c158a27860e0102cdd1dcf2
  378. CR:DOI:62ad3dd3dc742a32dd360c00b0f1fa4e
  379. CR:DOI:644b0ce19e450a09f9761d4c0febe015
  380. CR:DOI:66d3dbdffc22787fa9886b680bcbe5af
  381. CR:DOI:69046e808a898fdd77c4ac32e439e6b4
  382. CR:DOI:6920036664d2ce14878b939de0c03bee
  383. CR:DOI:6b3504fe47b788cd73d9f53626512a76
  384. CR:DOI:6cc99a5f77a6e9655d861ca2d1fc3c25
  385. CR:DOI:6cf032b3d733b8eafe7627257ce067d8
  386. CR:DOI:70c34359173ec1e91957314a02fc912c
  387. CR:DOI:7254dfd1e81a7ea8486654594db40a33
  388. CR:DOI:73b23397ddf1b35e6e13135126af8592
  389. CR:DOI:73b2cdb289567bf944b834884b982b23
  390. CR:DOI:7604bb4eccd4b0f35ba1fdcbedc183d2
  391. CR:DOI:76eef683079d96f46f56a6eccb733f17
  392. CR:DOI:77147f64e95d0ee78ea5ca66fa95c6e8
  393. CR:DOI:7969fde7934d219f61cfb5b37b270589
  394. CR:DOI:7988f4e33cb568e454f460cedbaa2940
  395. CR:DOI:7a71a1068c5ec01ab6e0764dcec5f8c2
  396. CR:DOI:7aec6782ab7f966603cc1751d65939c6
  397. CR:DOI:7b64fbf5d1021ab5bc68e15d258d1c25
  398. CR:DOI:7d2e2c64e14fe7c2a7ddfcb7017ccd67
  399. CR:DOI:7d6ce2d7fae52c13a3710fe89fc1d156
  400. CR:DOI:7f975170e17677f247daf22ae675d056
  401. CR:DOI:80ac657299c1a711fa7215edaa1fadcc
  402. CR:DOI:826f44adf4ce8ff6d4aa09a3564d0b24
  403. CR:DOI:830c5487c774f8a7a48f8f9e0c62029d
  404. CR:DOI:8364a8096db2e5fc7ac5fc7a06486748
  405. CR:DOI:8506cec6b1b04a68e434f042f7970dee
  406. CR:DOI:850ebb9e55e1f8cb092dddb52604c3ad
  407. CR:DOI:85b8b38f010838c55c8dd50923ee4b2b
  408. CR:DOI:893409d5f0d7ba865248047593988ab6
  409. CR:DOI:8a714e7544931f5a7aaaa026eb94bbaf
  410. CR:DOI:8cf276af02c1dee0d890220e9c4da472
  411. CR:DOI:8e2bad092ff079112b6816a5cc9f7230
  412. CR:DOI:8f3240a268c2269cf5f9bd1919a1db73
  413. CR:DOI:9001a5594f91dd6bf04eed25ac6ece98
  414. CR:DOI:90ca6feed9950cd48c5b12b7b7550739
  415. CR:DOI:926849ee14178552466c9adb43cafb90
  416. CR:DOI:92b0de46627d5069ae83b2a958b3cade
  417. CR:DOI:9333507aa0777a2dcb0ad6ece486f2c4
  418. CR:DOI:96250abe143582f71379fd5cc5a967ba
  419. CR:DOI:991f964bc1636d5dc191102bc25371bc
  420. CR:DOI:99200ff9965ceb04ad4d994ff98238f9
  421. CR:DOI:9a9d6cf3877fa597720e8174af13e90a
  422. CR:DOI:9a9e7f94d3dbf38ac747d552bbdff29e
  423. CR:DOI:9b9f4703054d4d499267c45c830f0f17
  424. CR:DOI:9d273044ed65d2e7fdb137fd33f1463b
  425. CR:DOI:9d68353d98e4176c52cd7ca96bd0a5ee
  426. CR:DOI:9e3503306da31f0700db99291beb5a46
  427. CR:DOI:9e91b940cf2d14742e8ff93036e10367
  428. CR:DOI:9ea1fcc42d82a8f13d9195b4bac5089f
  429. CR:DOI:9f701ec0217fe70d85c3837300571e40
  430. CR:DOI:a03981074b893893d5c9079ba13a439a
  431. CR:DOI:a42a65d4fb68f23b919fc8e857254388
  432. CR:DOI:a5039d8fa9a9e85d7e59d1cc57b33c8d
  433. CR:DOI:a55f83309a6e6f4ddbc632334a718bda
  434. CR:DOI:a6cfc8365ba65418d8e874a9af6bf662
  435. CR:DOI:aa6bb58cbee93a153689ff84b3815be0
  436. CR:DOI:ac2ff4083d127703e7482aa3c074fb69
  437. CR:DOI:afa00911a5a2cec5c1481f40f6a2acaa
  438. CR:DOI:afb3d02bc01ad3adc6010f37c10a92c3
  439. CR:DOI:afdbe434d5ad2e5e08c8e31bcdd84a86
  440. CR:DOI:b017ffb414d9bb215a114e2ea2875ca8
  441. CR:DOI:b18951172a5ba4e6e6fb8038c0ef1eb3
  442. CR:DOI:b2fbffadb731b73f5d5ca77aa60b3402
  443. CR:DOI:b4c581c4c9d64c391ae075e32142b7d3
  444. CR:DOI:b5eea92fc03256e3a3891b33ea68ee03
  445. CR:DOI:b694f1fe4184f2013ae0f676769dfddb
  446. CR:DOI:b6d1517c4f96004781d4914b8f63b6cc
  447. CR:DOI:b9317030589eded6198a6dff29ba59a1
  448. CR:DOI:bae7ec07e96a98c3bcc5253cf11d51a4
  449. CR:DOI:bc540372b9861b01e05bd4aaea395e0c
  450. CR:DOI:bc7f64d0251e73e5b7f31169b9aa0e5c
  451. CR:DOI:bd2ea72744822eef2e3068efbc1f6487
  452. CR:DOI:bea29a18d527d7c8aa1be9ec4df73f28
  453. CR:DOI:c0b6fccc2bce1614316f03e181e9ac45
  454. CR:DOI:c42f8e714142c02d04f01aefa1424fe5
  455. CR:DOI:c5086c57c4ad4641b7ee0e15b2ed35a2
  456. CR:DOI:c582662a81555a86aff0b8a29eeec24a
  457. CR:DOI:c5c6b676bc94c7d0bd1a1cd08c63b49b
  458. CR:DOI:c605aab953141c2376f3b8840f0d6d24
  459. CR:DOI:c6b0b2592ddf24cc5b656bbc4bbc13b2
  460. CR:DOI:c6f06e5cb3f5f8125ec5044919cba493
  461. CR:DOI:c7ae99a571f3ad477b69e76c8c773cf1
  462. CR:DOI:c91bcc94c1cca91ebafc0d98e0111e36
  463. CR:DOI:c961643b98eb32b71d42061b4a690ff2
  464. CR:DOI:ccd5d5c1dccfdd0379d60fc4914b9cc9
  465. CR:DOI:cdd117fd2789acc892d8beba9a9eca85
  466. CR:DOI:ce6f57a7754af2e2b88d4a54e9502aa3
  467. CR:DOI:ceeb91106002ee6438eacfb26f0b10a7
  468. CR:DOI:cf12a2e71e10680224350782afca9229
  469. CR:DOI:cfa2f2c6cc6af3632365c3ef86e7b61b
  470. CR:DOI:d059f5c267865beaebd7cd623ece4200
  471. CR:DOI:d0a6ae27f8da47002a176a60aae6a653
  472. CR:DOI:d0cf721f1b11c4947d9d584119e157fa
  473. CR:DOI:d236bdb9afe11cd60f12e3273f0048b2
  474. CR:DOI:d2884a88cacf48ac2b493190c74095af
  475. CR:DOI:d3bebd2106abfdceaa1e3492cd96f23d
  476. CR:DOI:d41a8ec870b77924908b44793d923353
  477. CR:DOI:d5c04bb4b0770dd9f52f5047e0a08bd3
  478. CR:DOI:d5cfc4aad6ac951a2c7a8958a321b5f0
  479. CR:DOI:d5db41d23de6623c6d13b0ffe1bc808b
  480. CR:DOI:d68983ed726f4d84bcc8a9342993d266
  481. CR:DOI:d6b3e528c1da9aa7d85a80ece2de9c49
  482. CR:DOI:d79ef6403423785d7445a287d9f5298f
  483. CR:DOI:d7e82ec5e5ad23fe3de0c2225396c4f1
  484. CR:DOI:d82d682cf09ec9411ac3793a322c1d58
  485. CR:DOI:d9fde7c28126ef69c9bed6360f3faa3c
  486. CR:DOI:dafc088b4572e68608d6120f4657c7f1
  487. CR:DOI:dbb615d69b352690f9b5e72343bb77ae
  488. CR:DOI:dfdd401efc8af1bb57368e5d50e31249
  489. CR:DOI:e27c5a4887971b847d54ab78959726af
  490. CR:DOI:e4b88dce4876a095de40d59ac19b0407
  491. CR:DOI:e685b2d71da14c2ca90bb1aeff3daa02
  492. CR:DOI:e76fc2def278ad7232367b9a92790427
  493. CR:DOI:e7d5997f6ba302aad44373195ab7f4fa
  494. CR:DOI:e940663c9b21ee851fa892d61de390ea
  495. CR:DOI:e988b075cb077114b3f7be1c30a2e105
  496. CR:DOI:ed606f5d19db857530752a358b3e0da4
  497. CR:DOI:ee68d2935f07f1456c07b4a6efab4f88
  498. CR:DOI:ee817dfd46decead39dbf489a2269574
  499. CR:DOI:eedd582daf4760b5c5c9016cfb9ce141
  500. CR:DOI:ef785e49306653503e384afbd5301d94

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://idwiki.org/Special:WithoutInterwiki"
Powered by MediaWiki
Powered by Semantic MediaWiki